Showing results 2 to 15 of 15
< previous
| Issue Date | Title | Author(s) |
| Jan-2021 | Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center | Duan, Wenbing; Liu, Xiaohong; Zhao, Xiaosu; Jia, Jinsong; Wang, Jing; Gong, Lizhong; Jiang, Qian; Zhao, Ting; Wang, Yu; Zhang, Xiaohui; Xu, Lanping; Shi, Hongxia; Chang, Yingjun; Liu, Kaiyan; Huang, Xiaojun; Qin, Yazhen; Jiang, Hao |
| 15-Nov-2022 | Cancer-Related Gene Mutations Drive Resistance to the Third-Generation Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia | Zhang, Xiaoshuai; Li, Zongru; Qin, Ya-Zhen; Gale, Robert Peter; Lai, Yueyun; Shi, Hongxia; Huang, Xiao Jun; Jiang, Qian |
| 31-Dec-2023 | Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review | Zhu, Li; Wang, Lei; Shi, Hongxia; Jiang, Lei; Li, Xin; Shao, Chunying; Yan, Yu; Dong, Bao; Zou, Wanzhong; Zuo, Li |
| Jun-2020 | Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center | Dou, Xuelin; Qin, Yazhen; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
| Jan-2021 | Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center (vol 20, pg e304, 2020) | Dou, Xuelin; Qin, Yazhen; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
| 2023 | Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia | Duan, Wenbing; Yang, Sen; Zhao, Ting; Hu, Lijuan; Qin, Yazhen; Jia, Jinsong; Wang, Jing; Lu, Shengye; Jiang, Hao; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
| Aug-2021 | A Deep Learning-Based Approach for Glomeruli Instance Segmentation from Multistained Renal Biopsy Pathologic Images | Jiang, Lei; Chen, Wenkai; Dong, Bao; Mei, Ke; Zhu, Chuang; Liu, Jun; Cai, Meishun; Yan, Yu; Wang, Gongwei; Zuo, Li; Shi, Hongxia |
| May-2024 | The impact of Bruton's tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia | Yang, Shenmiao; Wei, Rong; Shi, Hongxia; Wang, Yazhe; Lai, Yueyun; Zhao, Xiaosu; Lu, Jin; Schmitz, Norbert |
| Apr-2021 | Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia | Yu, Lu; Wang, Huifang; Gale, Robert Peter; Qin, Yazhen; Lai, Yueyun; Shi, Hongxia; Dou, Xuelin; Huang, Xiaojun; Jiang, Qian |
| Jan-2021 | The loss or absence of minimal residual disease of <0 center dot 1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis | Duan, Wenbing; Liu, Xiaohong; Jia, Jinsong; Wang, Jing; Gong, Lizhong; Jiang, Qian; Zhao, Ting; Wang, Yu; Zhang, Xiaohui; Xu, Lanping; Zhao, Xiaosu; Qin, Yazhen; Shi, Hongxia; Chang, Yingjun; Huang, Xiaojun; Jiang, Hao |
| Jan-2020 | Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells | Huang, Yumei; Wang, Yazhe; Chang, Yan; Yuan, Xiaoying; Hao, Le; Shi, Hongxia; Huang, Xiaojun; Liu, Yanrong |
| 2-Nov-2023 | Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a<3log Reduction of MRD2 Predicted Poor Survival | Duan, Wenbing; Jia, Jinsong; Wang, Jing; Liu, Xiaohong; Gong, Lizhong; Yu, WenJing; Zhu, Xiaolu; Ting, Zhao; Jiang, Qian; Ruan, Guorui; Zhao, Xiaosu; Wang, Yu; Shi, Hongxia; Xu, Lanping; Zhang, Xiaohui; Huang, Xiaojun; Jiang, Hao |
| 2009 | Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable to Unrelated Donor Transplantation for Patients with Hematologic Malignancies. | Huang, Xiao Jun; Xu, Lan-Ping; Liu, Kai Yan; Liu, Dai-Hong; Wang, Yu; Chen, Huan; Chen, Yu-Hong; Han, Wei; Wang, Jing-Zhi; Chen, Yao; Zhang, Xiao-Hui; Shi, Hongxia; Wang, Feng-Rong; Tang, Fei-Fei |
| 2023 | Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study | Zhang, Zhuxin; Hu, Qinglin; Tang, Xudong; Zhang, Min; Jia, Jinsong; Shi, Hongxia; Ding, Xiaoqing; Yang, Chen; Chen, Miao; Han, Bing |
